Riverhead Capital Management LLC Sells 7,650 Shares of Cardinal Health Inc (NYSE:CAH)
Riverhead Capital Management LLC trimmed its position in shares of Cardinal Health Inc (NYSE:CAH) by 14.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,304 shares of the company’s stock after selling 7,650 shares during the period. Riverhead Capital Management LLC’s holdings in Cardinal Health were worth $2,229,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently made changes to their positions in CAH. WP Advisors LLC purchased a new stake in shares of Cardinal Health during the first quarter worth $26,000. Bremer Bank National Association purchased a new stake in shares of Cardinal Health during the first quarter worth $27,000. Farmers National Bank purchased a new stake in shares of Cardinal Health during the first quarter worth $43,000. American Research & Management Co. purchased a new stake in shares of Cardinal Health during the first quarter worth $48,000. Finally, Investors Research Corp bought a new position in Cardinal Health in the 1st quarter worth approximately $53,000. Institutional investors and hedge funds own 88.54% of the company’s stock.
Several research analysts recently weighed in on CAH shares. Zacks Investment Research upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $59.00 price objective for the company in a research report on Tuesday, March 5th. ValuEngine cut shares of Cardinal Health from a “sell” rating to a “strong sell” rating in a research report on Monday, February 25th. Guggenheim began coverage on shares of Cardinal Health in a research report on Wednesday, April 17th. They set a “neutral” rating and a $51.00 target price for the company. Finally, Wolfe Research began coverage on shares of Cardinal Health in a research report on Tuesday, April 2nd. They set an “underperform” rating for the company. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and one has given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $56.20.
Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, May 9th. The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.43 by $0.16. The business had revenue of $35.23 billion for the quarter, compared to the consensus estimate of $35.09 billion. The business’s revenue was up 4.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.39 EPS. As a group, sell-side analysts forecast that Cardinal Health Inc will post 5.1 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Shareholders of record on Monday, July 1st will be given a dividend of $0.4811 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, June 28th. This represents a $1.92 annualized dividend and a dividend yield of 4.36%. Cardinal Health’s payout ratio is presently 38.20%.
Cardinal Health Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Featured Article: What is a blue-chip stock?
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.